BR112023022116A2 - Uma forma em estado sólido de tafamidis e um processo para sua preparação - Google Patents

Uma forma em estado sólido de tafamidis e um processo para sua preparação

Info

Publication number
BR112023022116A2
BR112023022116A2 BR112023022116A BR112023022116A BR112023022116A2 BR 112023022116 A2 BR112023022116 A2 BR 112023022116A2 BR 112023022116 A BR112023022116 A BR 112023022116A BR 112023022116 A BR112023022116 A BR 112023022116A BR 112023022116 A2 BR112023022116 A2 BR 112023022116A2
Authority
BR
Brazil
Prior art keywords
preparation
tafamidis
solid state
state form
crystalline
Prior art date
Application number
BR112023022116A
Other languages
English (en)
Portuguese (pt)
Inventor
Daniele Pengo
Giuseppe Barreca
Liming Huang
Luca Carcone
Massimo Zampieri
Piero Paravidino
Original Assignee
Quim Sintetica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quim Sintetica S A filed Critical Quim Sintetica S A
Publication of BR112023022116A2 publication Critical patent/BR112023022116A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
BR112023022116A 2021-04-26 2022-04-22 Uma forma em estado sólido de tafamidis e um processo para sua preparação BR112023022116A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21382362.8A EP4083027A1 (en) 2021-04-26 2021-04-26 A solid state form of tafamidis and a process for its preparation
PCT/EP2022/060716 WO2022229026A1 (en) 2021-04-26 2022-04-22 A solid state form of tafamidis and a process for its preparation

Publications (1)

Publication Number Publication Date
BR112023022116A2 true BR112023022116A2 (pt) 2024-01-09

Family

ID=75746555

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023022116A BR112023022116A2 (pt) 2021-04-26 2022-04-22 Uma forma em estado sólido de tafamidis e um processo para sua preparação

Country Status (8)

Country Link
US (1) US20240208915A1 (cg-RX-API-DMAC10.html)
EP (2) EP4083027A1 (cg-RX-API-DMAC10.html)
JP (1) JP7881608B2 (cg-RX-API-DMAC10.html)
CN (1) CN117255781A (cg-RX-API-DMAC10.html)
BR (1) BR112023022116A2 (cg-RX-API-DMAC10.html)
CA (1) CA3216325A1 (cg-RX-API-DMAC10.html)
MX (1) MX2023012460A (cg-RX-API-DMAC10.html)
WO (1) WO2022229026A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023091534A1 (en) * 2021-11-17 2023-05-25 Teva Pharmaceuticals International Gmbh Solid state form of tafamidis
WO2026159144A1 (en) 2025-01-22 2026-07-30 Inke, S.A. Solid forms of tafamidis methyl ethyl ketone solvate and processes for their manufacture

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1587821T6 (da) 2002-12-19 2025-05-26 Scripps Research Inst Sammensætninger og fremgangsmåder til stabilisering af trans-thyretin og inhibering af transthyretin-fejlfoldning
KR20130079353A (ko) * 2010-04-21 2013-07-10 키에시 파르마슈티시 엣스. 피. 에이. 트랜스티레틴 아밀로이드증 치료용 1-(2-플루오로비페닐-4-일)-알킬 카복실산 유도체
WO2013038351A1 (en) 2011-09-16 2013-03-21 Pfizer Inc. Solid forms of a transthyretin dissociation inhibitor
HUE056583T2 (hu) 2014-09-08 2022-02-28 Pfizer 6-Karboxi-2-(3,5-diklórfenil)-benzoxazol kristályos szilárd formái
GB2571950A (en) 2018-03-13 2019-09-18 Azad Pharma Ag New polymorph and new path to synthesize tafamidis
HRP20250159T1 (hr) 2019-05-16 2025-03-28 Assia Chemical Industries Ltd. Kruti oblici tafamidisa i njegovih soli
WO2021001858A1 (en) * 2019-07-04 2021-01-07 Msn Laboratories Private Limited, R&D Center Improved process for the preparation of 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid or its pharmaceutically acceptable salts and polymorphs thereof
WO2021019448A1 (en) 2019-08-01 2021-02-04 Honour (R&D) Process for the preparation of transthyretin dissociation inhibitor
WO2021152623A1 (en) * 2020-01-27 2021-08-05 Dr. Reddy’S Laboratories Limited Improved processes for the preparation of tafamidis and its meglumine salt
WO2022084790A1 (en) * 2020-10-19 2022-04-28 Glenmark Life Sciences Limited Process for preparation of tafamidis and salts thereof

Also Published As

Publication number Publication date
CN117255781A (zh) 2023-12-19
JP2024515770A (ja) 2024-04-10
EP4330237A1 (en) 2024-03-06
EP4083027A1 (en) 2022-11-02
MX2023012460A (es) 2023-12-14
CA3216325A1 (en) 2022-11-03
JP7881608B2 (ja) 2026-06-29
WO2022229026A1 (en) 2022-11-03
US20240208915A1 (en) 2024-06-27

Similar Documents

Publication Publication Date Title
CY1118475T1 (el) Αντιοξειδωτικοι ρυθμιστες φλεγμονης: c-17 ομολογοποιημενα παραγωγα ολεανολικου οξεος
BR112018000497A2 (pt) processo para preparação de um composto
CO7170149A2 (es) Producción mejorada de derivados de ácidos grasos
AR063710A1 (es) Proceso para la preparacion de acido 6-(3-cloro-2-fluorbencil)-1-[(s)-1-hidroximetil-2-metilpropil]-7-metoxi-4-oxo-1, 4-dihidroquinolon-3-carboxilico como inhibidores de integrasa del hiv e intermediarios de sintesis del mismo y composiciones que lo comprenden.
BR112017017892A2 (pt) processo para produzir etanol.
RU2019126333A (ru) 19-нор нейроактивные стероиды и способы их применения
GT201300253A (es) Preparacion de gadobutrol de alta pureza
EA201990455A1 (ru) КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ
BR112013014715B8 (pt) processo para produzir um artigo oco polimérico
RU2015142819A (ru) Натриевая соль (2s, 5r)-6-бензилокси-7-оксо-1,6-диаза-бицикло[3.2.1]октан-2-карбоновой кислоты и ее получение
BR112018069712A2 (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a.
AR118647A1 (es) Proceso de preparación de 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-deoxi-1-metilamino-d-glucitol
BR112021026899A2 (pt) Compostos heterocíclicos
BR112012017845A2 (pt) novo processo para produção de derivados de benzofenona
EA202190880A1 (ru) Кристаллическая форма морфолинохиназолинового соединения, способ ее получения и ее применение
BR112021024039A2 (pt) Sínteses de furanos substituídos
WO2018125983A8 (en) Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors
MX2023012460A (es) Una forma de tafamidis en estado solido y un proceso para su preparacion.
WO2020016847A3 (en) Purification process for preparation of eribulin and intermediates thereof
BR112023000065A2 (pt) Sal e forma cristalina de composto de pirimidina e métodos de preparação para os mesmos
BR112014000869A2 (pt) processo e éster vinílico
ATE294183T1 (de) Verbesserte herstellung von ceftiofur zwischenprodkten
EA202192581A1 (ru) Композиции d-метирозина и способы их получения
PE20180453A1 (es) Derivados de acido (s)-2'-vinil-abscisico
MX2024014493A (es) Formas solidas de heterociclilamidas como inhibidores de irak4